David Smadja to Biomarkers
This is a "connection" page, showing publications David Smadja has written about Biomarkers.
Connection Strength
0.283
-
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021 07; 19(7):1823-1830.
Score: 0.043
-
Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis. 2021 08; 24(3):407-411.
Score: 0.043
-
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 08; 24(3):505-517.
Score: 0.042
-
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020 11; 23(4):611-620.
Score: 0.040
-
Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells. Thromb Haemost. 2015 Oct; 114(4):735-47.
Score: 0.028
-
Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation. J Cell Mol Med. 2010 Jan; 14(1-2):449-51.
Score: 0.019
-
[Characterization of endothelial progenitor cells and putative strategies to improve their expansion]. J Soc Biol. 2009; 203(2):197-207.
Score: 0.019
-
Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock. Crit Care Med. 2021 11 01; 49(11):e1151-e1156.
Score: 0.011
-
Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol. 2021; 12:701273.
Score: 0.011
-
Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity. PLoS One. 2021; 16(5):e0252026.
Score: 0.011
-
Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support. J Am Coll Cardiol. 2018 05 15; 71(19):2106-2118.
Score: 0.009
-
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. Blood. 2016 12 08; 128(23):e59-e66.
Score: 0.008